{
    "title": "UPDATE 3-Drug developer 89Bio soars as NASH drug succeeds in mid-stage study",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11890035/89Bios-NASH-drug-succeeds-mid-stage-study-shares-soar.html",
    "date": "2023-03-22",
    "keywords": [
        "drug",
        "disease",
        "nash",
        "fibrosis",
        "liver",
        "trial",
        "treatment",
        "study",
        "market",
        "safety",
        "development",
        "march",
        "developer",
        "inc",
        "wednesday",
        "midstage",
        "pegozafermin",
        "steatohepatitis",
        "cause",
        "multibillion",
        "dollar",
        "nordisk",
        "profile",
        "diarrhea",
        "nausea",
        "value",
        "svb",
        "analyst",
        "thomas",
        "smith",
        "note",
        "scarring",
        "worsening",
        "placebo",
        "stage",
        "december",
        "headstart",
        "latestage",
        "advancement",
        "san",
        "company",
        "capitalization",
        "close",
        "trading",
        "form",
        "cirrhosis",
        "failure",
        "foundation",
        "reporting",
        "pratik",
        "jain",
        "bengaluru",
        "editing",
        "sriraj",
        "kalluvila"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}